Effects of β2-agonists and budesonide on interleukin-1β and leukotriene B4 secretion: Studies of human monocytes and alveolar macrophages

Journal of Asthma

Volumn 35, Issue 7, 1998, Pages 565-573

  Zetterlund, Anita ^a   Linden, Margareta ^b   Larsson, Kjell ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL INSTITUTE FOR WORKING LIFE   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Alveolar macrophages; Budesonide; Interleukin 1 ; Leukotriene B4; Monocytes; 2 agonists

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; FORMOTEROL; INTERLEUKIN 1BETA; LEUKOTRIENE B4; SALBUTAMOL; SALMETEROL; TERBUTALINE; ZYMOSAN; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; INTERLEUKIN 1;

ADULT; ARTICLE; CELL TRANSFORMATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; MONOCYTE; NORMAL HUMAN; METABOLISM; MIDDLE AGED; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-AGONISTS; ADULT; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-1; LEUKOTRIENE B4; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; MONOCYTES;

EID: 0031595339     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909809048959     Document Type: Article

References (34)

1. Dunnill MS: The pathology of asthma with special reference to changes in bronchial mucosa. J Clin Pathol 13:27-33 (1960).
2. Marini M, Avoni E, Hollemborg J, Mattoli S: Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from nonatopic patients with symptomatic asthma. Chest 102(3):661-669 (1992).
3. Calhoun WJ, Jarjour NN, Gleich GJ, Stevens CA, Busse WW: Increased airway inflammation with segmental versus aerosol antigen challenge. Am Rev Respir Dis 147:1465-1471 (1993).
4. Melewicz FM, Kline LE, Cohen AB, Spiegelberg HL: Characterization of Fc receptors for IgE on human alveolar macrophages. Clin Exp Immunol 49:367-370 (1982).
5. Carroll MP, Curham SR, Walsh G: Activation of neutrophils and monocytes after allergen-and histamine-induced bronchoconstriction. J Allergy Clin Immunol 75:290-296 (1985).
6. 4, in bronchoalveolar lavage in bronchial asthma and other diseases. J Allergy Clin Immunol 84:19-26 (1989).
7. Resnick MB, Weller FP: Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 8:349-355 (1993).
8. Borish L, Mascali JJ, Dishuck J, Beam WR, Martin RJ, Rosenwasser LJ: Detection of alveolar macrophage-derived IL-1β in asthma. Inhibition with corticosteroids. J Immunol 149:3078-3082 (1992).
9. Mattoli S, Mattoso VL, Soloperto M, Allegra L, Fasoli A: Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol 87:794-802 (1991).
10. Hallsworth MP, Soh CPC, Lane SJ, Arm JP, Lee TH: Selective enhancement of GM-CSF, TNF-alfa, IL-1β and IL-8 production by monocytes and macrophages of asthmatic subjects. Eur Respir J 7:1096-1102 (1994).
11. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA: Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related cell lines. J Clin Invest 76:2003-2011 (1985).
12. 2-Agonists as anti-inflammatory therapies in the lung. Agents Actions 41(Suppl):27-49 (1993).
13. Anderson G: Pharmacology of formoterol: an innovative bronchodilator. Agents Actions 34:97-115 (1991).
14. Hjemdahl P, Larsson K, Johansson M-C, Zetterlund A, Eklund A: β-Adrenoceptors in human alveolar macrophages isolated by elutriation. Br J Clin Pharmacol 30:673-682 (1990).
15. 2-adrenergic receptors on human alveolar macrophages. Am Rev Respir Dis 139:552-555 (1989).
16. Labarca C, Paigen K: A simple rapid and sensitive DNA assay procedure. Anal Biochem 102:344-352 (1980).
17. Werb Z, Foley R, Munck A: Interactions of glucocorticoids with macrophages. Identification of glucocorticoid receptors in monocytes and macrophages. J Exp Med 147:1684 (1978).
18. Knudsen P, Dinarello C, Strom T: Glucocorticoids inhibit transcriptional and posttranscriptional expression of interleukin 1 in U937 cells. J Immunol 139:4129-4134 (1987).
19. Kern J, Lamb R, Reed J: Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest 81:237-244 (1988).
20. Linden M, Brattsand R: Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: Differential sensitivity of GM-CSF, IL-1β and IL-6. Pulmon Pharmacol 7:43-47 (1994).
21. Strieter RM: Differential regulation of tumor necrosis factor-a in human alveolar macrophages and periferal blood monocytes: A cellular and molecular analysis. Am J Respir Cell Mol Biol 1:57-63 (1989).
22. Linden M: The effect of β2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes. Br J Pharmacol 107:156-160 (1992).
23. Sebaldt RJ, Sheller JR, Oates JA, Jackson Roberts L: Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci 87:6974-6978 (1990).
24. 4 as a mediator of early and late reactions to antigens in humans: The effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol 83:634-642 (1989).
25. 4 levels in patients with obstructive pulmonary disease. Chest 99:289-291 (1991).
26. Dworski R, Fitzgerald GA, Oates JA, Sheller JR: Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 149:953-959 (1994).
27. Assem ESK, Schild HO: Inhibition by sympathomimetic amines of histamine release induced by antigen in passively sensitized human lung. Nature 224:1028-1029 (1964).
28. Grönneberg R, Zetterström O: Inhibition of anti-IgE induced skin response in normals by formoterol, a new β2-adrenoceptor agonist, and terbutaline. 2. Effect on the late phase reaction. Allergy 45:340-346 (1990).
29. Twentyman OP, Finnerty JP, Harris A, Palmer J, Holgate ST: Protection against allergen-induced asthma by salmeterol. Lancet 336:1338-1342 (1990).
30. 2-agonists in asthma. Lancet 337:301-302 (1991).
31. Baker AJ, Palmer J, Johnson M, Fuller RW: Inhibitory actions of salmeterol on human airway macrophages and blood monocytes. Eur J Pharmacol 264:301-306 (1994).
32. Martin TR, Goodman RB: The role of lung mononuclear cells in asthma. Immunol Allergy Clin North Am 10:295-308 (1990).
33. 4 production by human alveolar macrophage: a potential mechanism for amplifying inflammation in lung. Am Rev Respir Dis 129:106-111 (1984).
34. Johnson M: The pharmacology of salmeterol. Lung 168:115-119 (1990).